Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Intestinal Blockage Lawsuit Filed Over Failed To Disclose Extent of Serious Stomach Risks Illinois woman required multiple emergency visits due to an Ozempic intestinal blockage, according to a lawsuit filed against the drug maker over inadequate warnings provided about the potential stomach side effects February 12, 2024 Irvin Jackson Add Your Comments Novo Nordisk faces a product liability lawsuit brought by an Illinois woman, which indicates that the popular diabetes and weight loss drug Ozempic caused an intestinal blockage, which left her with severe and permanent gastrointestinal injuries. The complaint (PDF) was filed by Mary Arredondo on February 9 in the U.S. District Court for the Northern District of Illinois, alleging that information about the potential Ozempic stomach risks have not been adequately disclosed to users and the medical community. Ozempic (semaglutide) was initially approved for the treatment of people with Type 2 diabetes, and it is part of a popular new class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, amid aggressive advertisements that promoted the weight loss benefits, Ozempic has been increasingly prescribed as a diet drug in recent years, making it a blockbuster treatment that is now used by millions of Americans. As a result of the popularity of Ozempic for weight loss, Novo Nordisk has introduced a higher dose version under the brand name Wegovy, which is specifically approved as a diet drug. However, it contains the same active ingredient. Although advertisements promote the drug as safe and effective, with few long-term side effects, Arredondo and other former users are now pursuing Ozempic lawsuits and Wegovy lawsuits against Novo Nordisk, each raising similar allegations that the widespread use of the drugs has made it clear that the drug label fails to disclose the risk of intestinal blockages, stomach paralysis and other long-lasting side effects. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Ozempic Intestinal Blockage Injuries According to the lawsuit, Arredondo began using Ozempic in July 2021, after being prescribed the diabetes drug by her physician. However, the lawsuit indicates that side effects caused her to develop gastroparesis, which involves delayed emptying of the stomach, leading her to develop an intestinal blockage from Ozempic. Intestinal blockages occur when digested food from the stomach cannot pass normally through the bowels. This can be caused by surgeries or some medications, involving severe symptoms like nausea, vomiting, abdominal pain and constipation. The condition can be treated through the use of a tube that is surgically inserted to relieve the pressure, but in some cases more extensive surgery is needed. Arredondo’s lawsuit indicates she exerienced severe vomiting, diarrhea, dehydration, dizziness, and stomach pain after taking Ozempic. In addition to needing to take medications to treat the condition, the complaint indicates Arredondo required multiple emergency room visits for her intestinal blockage. “Defendants knew or should have known of the causal association between the use of GLP-1RAs and the risk of developing gastroparesis and its sequelae, but they ignored the causal association,” the lawsuit states. “Defendants not only knew or should have known that their GLP-1RAs cause delayed gastric emptying, resulting in risks of gastroparesis, but they may have sought out the delayed gastric emptying effect due to its association with weight loss.” A study published in October found that Ozempic triples the risk of the stomach paralysis among users when compared to users of non-injectable weight loss drugs. The research compared the gastrointestinal side effects of Ozempic and other injectable GLP-1 agonists like liraglutide (Victoza and Saxenda) against those experienced by users of Contrave (bupropion-naltrexone), an oral weight management medication. The findings indicated that about 1% of Ozempic users developed stomach paralysis, compared to 0.7% of liraglutide users and around 0.3% of those on Contrave. The study highlighted that injectable semaglutide and liraglutide were significantly more likely to cause stomach paralysis and bowel obstruction than Contrave. February 2024 Ozempic Lawsuit Update Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order consolidating all Ozempic intestinal blockage lawsuits together with claims against the manufacturers of other GLP-1RA medications, which have been centralized before U.S. District Judge Gene E.K. Pratter in the U.S. District Court for the Eastern District of Pennsylvania for coordinated pretrial proceedings. As part of the coordinated management of the litigation, it is expected that the parties will select small groups of bellwether claims involving representative injuries, to prepare for a series of early bellwether trials to help the parties gauge how juries may respond to certain evidence and testimony that will be repeated by multiple plaintiffs. Following any early bellwether trials, if the parties are unable to reach Ozempic settlements or another resolution for intestinal blockage lawsuits being pursued by former users, the claim filed by Arredondo and other individual plaintiffs may later be remanded back to the U.S. District Court where it was originally filed for trial. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Diabetes, Diabetes Drug, Gastroparesis, Intestinal Blockage, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Wegovy, Weight Lost Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues October 28, 2025 Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges October 21, 2025 Ozempic, Wegovy Kidney Side Effects Highlighted in New Study October 10, 2025 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: yesterday) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025) Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: 2 days ago) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 5 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)
Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: yesterday) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025)
Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (Posted: 2 days ago) Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Problems Prompted FDA Warnings Over Off-Label Use (10/15/2025)Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (10/09/2025)FDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Four BioZorb Breast Marker Lawsuits Set for Trial Between Jan. and April 2026 (Posted: 5 days ago) A federal judge has set key scheduling deadlines for the four first bellwether trials over claims that BioZorb breast markers are defectively designed. MORE ABOUT: BIOZORB LAWSUITLawyers in BioZorb Implant Lawsuits Request Updated Deadlines in Pretrial Schedule (10/15/2025)Tamoxifen Side Effects Linked to Uterine Tumors in Breast Cancer Patients: Study (09/16/2025)Five Women File Joint Lawsuit Over BioZorb Breast Implant Side Effects (09/09/2025)